For Patients> Chronic Constipation

Chronic Constipation

Ending the Cycle of Futility for Patients with Chronic Constipation

The Current Situation

Chronic constipation affects approximately 14% of the adult population in the U.S. The most common types are chronic idiopathic constipation (CIC) and irritable bowel syndrome-associated constipation (IBS-C). Today, chronic constipation is treated with fiber, over-the-counter laxatives, and/or prescription drugs.

What’s Needed

Current drugs for chronic constipation have very low response rates – under 20%. Because of these low response rates, chronic constipation patients often cycle through multiple medications without beneficial results. Approximately half of patients who initiate pharmacotherapy do not experience an adequate clinical response.

Anji Is Bridging the Gap

We recognize an urgent need for constipation therapy that’s more effective than current medications. We see an opportunity for consistently high response rates that can transform the lives of patients.

Learn About Our Clinical Trial

Anji Pharmaceuticals has a clinical trial for a new drug candidate for chronic constipation. Learn more and see if you’re eligible at the link below.

Additional Patient Resources

Get more information on chronic constipation through these communities:

Contact us to learn more about the therapies we're working on and the conditions they aim to treat.